Olanzapine in the treatment of delirium

Psychosomatics

Volumn 39, Issue 5, 1998, Pages 422-430

  Sipahimalani, Anil ^a   Masand, Prakash S ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; CONSCIOUSNESS; DELIRIUM; DOSE RESPONSE; DRUG TOLERANCE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MENTAL HEALTH; RATING SCALE; SLEEP WAKING CYCLE; SYMPTOMATOLOGY;

EID: 0031681225     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(98)71301-5     Document Type: Article

References (20)

1. Lipowski ZJ: Delirium (acute confusional states). JAMA 1987; 258:1789-1792
2. Trzepacz PT, Teageu GB, Lipowski ZJ: Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry 1985; 7:101-106
3. Weddington WW: The mortality of delirium: an underappreciated problem. Psychosomatics 1982; 3:1232-1235
4. Inouye SK: The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994;97:278-288
5. Anthony JC, Leresche L, Niaz U, et al: Limits of the "Mini Mental State" as a screening test for dementia and delirium among hospital patients. Psychol Med 1982; 12:397-408
6. Trzepacz PT, Baker RW, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988;23:89-97
7. Shapiro BA, Warren J, Egol AB, et al: Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med 1995; 23:1596-1600
8. Gupta S, Masand PS: Olanzapine: review of its pharmacology and indications in clinical practice. Primary Psychiatry 1997; 53:73-82
9. Sipahimalani A, Masand PS: Use of risperidone in delirium: case reports. Ann Clin Psychiatry 1997; 9:105-107
10. Sipahimalani A, Sime R, Masand P: Treatment of delirium with risperidone. International Journal of Geriatric Psychopharmacology (in press)
11. Casey DE: Acute extrapyramidal syndromes, in Contemporary Issues in the Treatment of Schizophrenia, edited by Shriqui CL, Nasrallah HA. Washington, DC, American Psychiatric Press, Inc., 1995, pp. 535-550
12. Gelfand SB, Indelicato J, Benjamin J: Using intravenous haloperidol to control delirium. Hosp Community Psychiatry 1992; 33:235-236
13. Moulaert P: Treatment of acute nonspecific delirium with i.v. haloperidol in surgical intensive care patients. Acta Anaesthesiol 1989; 40:183-186
14. Tesar GE, Murray GB, Cassem NH: Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985; 5:344-347
15. Menza MA, Murray GB, Holmes VF, et al: Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung 1988; 17:238-241
16. Chouinard G, Jones B, Remington G, et al: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia patients. J Clin Psychopharmacol 1993; 13:405-408
17. Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151:825-835
18. Masand PS: Using newer antipsychotic agents in primary care. Primary Psychiatry 1997; 58:64-68
19. Keepers GA, Clappison VJ, Casey DE: Initial anticholinergic prophylaxis for acute neuroleptic-induced extrapyramidal symptoms. Arch Gen Psychiatry 1983;40:1113-1117
20. Angermeyer MC, Kuhn L, Goldstein JM: Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 1990;16:293-307